Systematic detection of familial hypercholesterolaemia in primary health care: A community based prospective study of three methods

Heart Lung and Circulation

Volumn 24, Issue 3, 2015, Pages 250-256

  Kirke, Andrew B ^a   Barbour, Rita A ^a   Burrows, Sally ^b   Bell, Damon A ^b,c   Vickery, Alistair W ^a   Emery, Jon ^a,d   Watts, Gerald F ^b,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c ROYAL PERTH HOSPITAL   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Case detection; Familial hypercholesterolaemia; General practice; Preventative cardiology; Primary health care; Screening

Indexed keywords

ADULT; AGE; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENERAL PRACTICE DATABASE; GENETIC SCREENING; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; MALE; PATHOLOGY LABORATORY DATABASE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLIC HEALTH; RISK ASSESSMENT; SCREENING; SEX DIFFERENCE; WORKPLACE HEALTH CHECK; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; GENETICS; HYPERLIPOPROTEINEMIA TYPE II; MIDDLE AGED; MULTICENTER STUDY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PROCEDURES;

ADULT; AGED; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES;

EID: 84923259638     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2014.09.011     Document Type: Article

References (27)

1. Austin M., Hutter C., Zimmern R., Humphries S. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol 2004, 160(5):407-420.
2. Goldstein J.L., Hobbs H.H., Brown M.S. Familial Hypercholesterolaemia. The metabolic and molecular basis of inherited disorders 1995, 1981-2030. McGraw Hill, New York. 7th ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
3. Steyn K., Goldberg Y.P., Kotze M.J., Steyn M., Swanepoel A.S.P., Fourie J.M., et al. Estimation of the prevalence of familial hypercholesterolaemia in a rural Afrikaner community by direct screening for three Afrikaner founder low density lipoprotein receptor gene mutations. Hum Genet. 1996, 98(4):479-484.
4. Hamilton-Craig I., van Bockxmeer F.M., Michaelides C., Kostner K.M. Current Initiatives for Detecting Patients with Familial Hypercholesterolemia in Primary Care. LipidSpin. 2014, (March 2014):5-10.
5. Qureshi N., Humphries S.E., Seed M., Rowlands P., Minhas R., Group N.G.D. Identification and management of familial hypercholesterolaemia: what does it mean to primary care?. British Journal of General Practice. 2009, 59(567):773-778.
6. Kirke A., Watts G.F., Emery J. Detecting familial hypercholesterolaemia in general practice. Australian Family Physician. 2012, 41(12):965-968.
7. Watts G.F., Gidding S., Wierzbicki A.S., Toth P.P., Alonso R., Brown W.V., et al. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation. Int J Cardiol. 2014, 171(3):309-325.
8. Royal Australian College of General Practitioners Guidelines for preventative activities in general practice (7th edition) 2009, RACGP Red Book. 7th edition.
9. Wilson J., Jungner G. Principles and practice of screening for disease 1968, #34:1-163. World Health Organization. Public Health Papers, WHO Chronicle Geneva, World Health Organization.
10. World Health Organization 1999 Familial Hypercholesterolaemia (FH). Report of a second WHO consultation 1999, World Health Organization, Geneva.
11. Watts G., Sullivan D., Poplawski N., van Bockxmeer F., Hamilton-Craig I., Clifton P., et al. Familial hypercholesterolaemia: A model of care for Australasia. Atherosclerosis Suppl. 2011, 12(2):221-231.
12. Marks D., Wonderling D., Thorogood M., Lambert H., Humphries S.E., Neil H.A. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2000, 4(29):123.
13. Neil H.A., Hammond T., Huxley R., Matthews D., Humphries S.E. Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: Prospective registry study. BMJ. 2000, 321(7254):148.
14. Hamilton-Craig I. Case-finding for familial hypercholesterolemia in the Asia-Pacific region. Semin Vasc Med. 2004, 4:87-92.
15. Gray J., Jaiyeola A., Whiting M., Modell M., Wierzbicki A.S. Identifying patients with familial hypercholesterolaemia in primary care: an informatics-based approach in one primary care centre. Heart. 2008, 94(6):754-758.
16. Leren T.P., Finbroud T.H., Manshaus T.E., Ose L., Berge K.E. Diagnosis of Familial Hypercholesterolemia in General Practice Using Clinical Diagnostic Criteria or Genetic Testing as Part of Cascade Genetic Testing. Community Genetics. 2008, 11:26-35.
17. Wald D.S., Bestwick J.P., Wald N.J. Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis. BMJ. 2007, 335(7620):599.
18. Melbourne Institue of Applied Economic and Social Research. Living in Australia HILDA 20122012. Available from: http://www.livinginaustralia.org/results/lifestyle.html. http://www.livinginaustralia.org/results/lifestyle.html.
19. Bell D.A., Hooper A.J., Bender R., McMahon J., Edwards G., van Bockxmeer F.M., et al. Opportunistic screening for familial hypercholesterolaemia via a community laboratory. Annals of Clinical Biochemistry. 2012, 49(6):534-537.
20. Bell D.A., Garton-Smith J., Vickery A., Kirke A.B., Pang J., Bates T.R., et al. Familial Hypercholesterolaemia in Primary Care: Knowledge and Practices among General Practitioners in Western Australia. Heart, Lung and Circulation. 2014, 23(4):309-313.
21. Medicare Local Bentley Armadale. Canning Data Extraction Tools 2013 [cited 2013 28/7/2013]. Available from: http://canningtool.com.au/. http://canningtool.com.au/.
22. Benn M., Watts G.F., Tybjaerg-Hansen A., Nordestgaard B.G. Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication. Journal of Clinical Endocrinology & Metabolism. 2012, 97(11):3956-3964.
23. Bell DA, Kirke AB, Barbour R, Southwell L, Pang J, Burrows S, et al. Can Patients be Accurately Assessed for Familial Hypercholesterolaemia in Primary Care? Heart, Lung and Circulation. Accepted for publication, 12 August 2014.
24. Friedewald W, Levy R, Fredrickson D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem. 1072; 18(6):499-502.
25. Hooper A.J., Nguyen L.T., Burnett J.R., Bates T.R., Bell D.A., Redgrave T.G., et al. Genetic analysis of familial hypercholesterolaemia in Western Australia. Atherosclerosis. 2012, 224(2):430-434.
26. Bell D.A., Bender R., Hooper A.J., McMahon J., Edwards G., van Bockxmeer F.M., et al. Impact of interpretative commenting on lipid profiles in people at high risk of familial hypercholesterolaemia. Clinica Chimica Acta; International Journal of Clinical Chemistry. 2013, 422:21-25.
27. Vickery AW, Bell D, Garton-Smith J, Kirke AB, Pang J, Watts GF. Optimising the Detection and Management of Familial Hypercholesterolaemia: Central Role of Primary Care and its Integration with Specialist Services. Heart, Lung and Circulation. Accepted for publication, 11 July 2014.